Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. logo
REGN

Regeneron Pharmaceuticals, Inc. (REGN)

$761.241.27%

Market is closed
– opens on 8 PM, 02 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$752.405
Day's Range
$768.295
$538.01
52-Week Range
$769.63
1 month return2.8%
3 month return31.11%
1 year return20.07%
5 year return101.19%

Company Information

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, its unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in its laboratories. Its medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.
OrganizationRegeneron Pharmaceuticals, Inc.
Employees10915
CEODr. Leonard S. Schleifer M.D., Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 26 analysts ratings

Buy
57%
Buy
38%
Hold
3%
Sell

Based on 26 Wall street analysts offering stock ratings for Regeneron Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 5.39%

Current

$761.24

Target

$802.25

Recommendation Trend

Based on 26 analyst

Current1M Ago3M Ago
Buy
15
19
18
Hold
10
13
13
Sell
1
1
2
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
81.9B
Book Value
$200.93
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
3.98
PE Ratio
188.87
PEG Ratio
8.85
Wall Street Target Price
802.25

Valuation

Trailing PE188.87
Forward PE17.48
Price/Book (mrq)
3.74
Enterprise Value
75.9B
Enterprise Value/Revenue
5.53
Enterprise Value/Ebitda
11.84

Technicals

Beta
0.2
50 Day MA
729.04
200 Day MA
660.66

Sustainability

Rating Date2019-01-01
Total Esg
22.33
Total Esg Percentile
26.82
Environment Score1.51
Environment Score Percentile2.0
Social Score13.94
Social Score Percentile2.0
Governance Score5.88
GovernanceScorePercentile2.0
Controversy Level2.0

Institutional Holdings

FMR Inc

9.34%

Vanguard Group Inc

7.94%

Capital World Investors

5.72%

JPMorgan Chase & Co

5.21%

State Street Corporation

4.64%

Wellington Management Company LLP

2.24%

Discover more

Frequently Asked Questions

What is Regeneron Pharmaceuticals, Inc. share price today?

Can Indians buy Regeneron Pharmaceuticals, Inc. shares?

How can I buy Regeneron Pharmaceuticals, Inc. shares from India?

Can Fractional shares of Regeneron Pharmaceuticals, Inc. be purchased?

What are the documents required to start investing in Regeneron Pharmaceuticals, Inc. stocks?

What are today’s High and Low prices of Regeneron Pharmaceuticals, Inc.?

What are today’s traded volumes of Regeneron Pharmaceuticals, Inc.?

What is today’s market capitalisation of Regeneron Pharmaceuticals, Inc.?

What is the 52 Week High and Low Range of Regeneron Pharmaceuticals, Inc.?

How much percentage Regeneron Pharmaceuticals, Inc. is down from its 52 Week High?

How much percentage Regeneron Pharmaceuticals, Inc. is up from its 52 Week low?

What are the historical returns of Regeneron Pharmaceuticals, Inc.?

Who is the Chief Executive Officer (CEO) of Regeneron Pharmaceuticals, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*